Updated 20:01 GMT, 18 Nov 2026 SPX 7,321.77 -0.26% NDX 27,068.70 +0.25% VIX 24.83 -2.47% GOLD 3,724.40 -3.62% CL 82.44 -4.15% BTC 62,664.99 -3.43%
NAS100 27,069 +0.25% S&P 7,322 −0.26% GOLD $3,724 −3.62% BTC $62,665 −3.43% VIX 24.83 −2.47% latest tape · as of 20:01 UTC · 18 Nov
The Screen · Consumer Cyclical · Furnishings, Fixtures & Appliances

Aterian Inc

ATER · NASDAQ · USD · Market cap $220M · 74 employees

Aterian, Inc., together with its subsidiaries, operates as a consumer products company in North America, Chile, Colombia, Argentina, and internationally.

PASS · Titan Ethical · score 70.0
0.95 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 20:01 UTC · 18 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price0.95 USD at the 17 Nov 2026 close
  • Our regime readAccumulation, as of 16 Nov 2026
  • Ethical screenPasses, score 70.0 out of 100
  • OptionsOpen interest leans heavily to calls (put/call 0.03)
  • Last reviewed17 Nov 2026 (2 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-17).

Current read
Accumulation ?
Screened · screened 2026-11-17
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.03, read 2026-11-17
  • Ethical passes the values gate
Price0.95 USD
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Accumulation0.76+25.4% to today ✓Markdown gives way to Accumulation after a 24% rise in 3 weeks
2026-10-11Read Markdown0.61+55.5% to today Markup gives way to Markdown after a 9% slide in 2 weeks
2026-09-24Read Markup0.67+41.7% to today ✓Distribution gives way to Markup after a 44% slide in 12 weeks
2026-07-02Read Distribution1.20-20.9% to today ✓First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Aterian Inc holds its Accumulation at $0.95. The statistical read favours the sellers, held for 26 days.

As held on the ledger · 2026-11-17
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 26 days
Price at the screen$0.95
ValuationN/A trailing · -0.38 forward price to earnings
Values screenPASS · score 70.0
Beta1.35
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 15.65% Below 33% Interest-bearing debt is just 15.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 24.75% Below 49% Money owed to the company is 24.7% of assets, under the 49% limit. Pass
Revenue purity 0.15% Below 5% Only 0.2% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Aterian clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 16%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when ATER's ethical verdict changes

Today ATER passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E-0.4x
EPS, trailing-2.07
EPS, forward-2.24
Revenue growth-92.0%revenue is shrinking
Profit margin-24.5%currently unprofitable
Return on equity-104.0%not currently earning a positive return on equity
FCF yield-1.86%
Debt to equity0.30minimal debt: a conservative balance sheet
Current ratio2.13comfortably covers its short-term bills
Beta1.35moves a little more than the market
Short interest, float0.00%
52-week range0.35 - 1.87
MoatNONE
Market cap$220M
Employees74

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

ATER trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Accumulation $0.88 +3.1% Entry 13

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-11-08 Accumulation $0.85 +12.6% Entry 12

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-11-01 Accumulation · changed $0.76 +20.9% Entry 11

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 20.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-10-25 Markdown $0.63 +6.9% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 6.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-10-18 Markdown $0.59 -4.1% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-10-11 Markdown · changed $0.61 -8.8% Entry 8

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-10-02 Markup $0.67 +0.0% Entry 7

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-09-24 Markup · changed $0.67 +38.5% Entry 6

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 38.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-08-22 Distribution $0.48 -62.8% Entry 5

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 62.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

2026-07-22 Distribution $1.30 +8.3% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 26%.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on ATER

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in ATER's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming ATER
DatePoliticianPartyTypeAmount
2026-10-26 Josh Gottheimer Democrat buy 1K–15K
2026-10-26 Josh Gottheimer Democrat buy 1K–15K
2026-10-13 Ro Khanna Democrat buy 1K–15K
2026-10-13 Ro Khanna Democrat sell 1K–15K
2026-10-07 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $1.12 +5.4% · $1,054 +5.4%
2 months $0.67 +75.1% · $1,751 +75.1%
3 months $0.58 +103.5% · $2,035 +103.5%
6 months $0.89 +32.1% · $1,321 +32.1%
1 year $1.41 -16.3% · $837 -16.3%
2 years $2.47 -52.2% · $478 -52.2%
3 years $6.50 -81.9% · $181 -81.9%
5 years $189.72 -99.4% · $6 -99.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ATER does next, these words stay.

Aterian Inc · ATER · Accumulation · $0.95
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.